Vladislav Bekerman, MD
Ophthalmology · Simi Valley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 8 years
- Drexel University College of Medicine, 2018
Offices
1 location · Miramar Eye Specialists Medical Group Inc · 26 clinicians in this group
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bekerman’s office at (805) 527-1417 to ask if they take your plan before you enroll.
California Medical Board record
Licence A177459 · Current
Licensed to practise in California · since 2022 · expires 2028-04-30 · Drexel University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Ophthalmology - Ophthalmology
Original Medicare doctor bills
$178,645
Medicare paid this office $178,645 for 696 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Established patient problem focused exam of visual system | 393 | $45,222 | $71 |
| Removal of cataract with insertion of prosthetic lens | 47 | $34,347 | $458 |
| Established patient complete exam of visual system | 274 | $28,072 | $95 |
| Placement of amniotic membrane on eye surface for wound healing | 11 | $11,899 | $992 |
| New patient complete exam of visual system | 95 | $10,213 | $108 |
See all 17 services
| Established patient problem focused exam of visual system | 393 | $45,222 | $71 |
| Removal of cataract with insertion of prosthetic lens | 47 | $34,347 | $458 |
| Established patient complete exam of visual system | 274 | $28,072 | $95 |
| Placement of amniotic membrane on eye surface for wound healing | 11 | $11,899 | $992 |
| New patient complete exam of visual system | 95 | $10,213 | $108 |
| Closure of tear duct opening using plug | 47 | $8,970 | $176 |
| Microfluid analysis of tears | 127 | $6,080 | $22 |
| Removal of recurring cataract in lens capsule using a laser | 17 | $5,903 | $268 |
| Exam of visual field with extended testing | 60 | $4,047 | $52 |
| Imaging of retina | 101 | $3,334 | $32 |
| Imaging of optic nerve | 101 | $3,131 | $28 |
| New patient problem focused exam of visual system | 49 | $3,087 | $63 |
| Analysis of substance using immunoassay technique, multiple step method | 125 | $3,051 | $11 |
| Measurement of corneal curvature and depth of eye | 59 | $3,013 | $22 |
| Injection into skin growth, 1-7 growths | 11 | $688 | $43 |
| Exam of the internal drainage system of eye | 13 | $260 | $19 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $95 | None |
Procedures Medicare counted
| Cataract surgery | 225 | More than 85% of doctors who do this |
Procedures year by year
| Procedure | 2022 | 2023 | 2024 |
|---|---|---|---|
| Closure of tear duct opening using plug | 15 | 85 | 51 |
| Removal of cataract with insertion of prosthetic lens | – | 41 | 75 |
| Removal of recurring cataract in lens capsule using a laser | – | – | 22 |
| Injection into skin growth, 1-7 growths | – | – | 16 |
| Placement of amniotic membrane on eye surface for wound healing | – | – | 12 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
696 Original Medicare patients in 2024. Average age 75 · Under 65 4% · 85 and older 15% · Women 60% · Also on Medicaid 8% · Health risk score 1.08. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 71% · Coronary heart disease 28% · Diabetes 25% · Chronic kidney disease 21% · Atrial fibrillation 19% · Depression 16% · Heart failure 15% · Cancer 15% · COPD 12% · Stroke 10% · Dementia 5%.
The office billed $534,990, Medicare allowed $238,898 and paid $178,645; for 2,420 services of 32 kinds; $95 of it was for drugs given in the office and $178,551 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 696 | 2,420 | 75 | 1.08 | $534,990 | $178,645 |
| 2023 | 585 | 2,096 | 76 | 1.12 | $450,162 | $156,699 |
| 2022 | 193 | 589 | 75 | 1.01 | $108,090 | $40,197 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Established patient problem focused exam of visual system | 323 | $38,711 | $72 |
| Established patient complete exam of visual system | 199 | $21,038 | $99 |
| Removal of cataract with insertion of prosthetic lens | 29 | $18,810 | $459 |
| New patient complete exam of visual system | 159 | $16,278 | $102 |
| Closure of tear duct opening using plug | 75 | $15,392 | $181 |
| Exam of visual field with extended testing | 60 | $4,497 | $54 |
| Microfluid analysis of tears | 67 | $3,525 | $22 |
| Imaging of optic nerve | 101 | $3,399 | $27 |
| Imaging of retina | 95 | $3,332 | $33 |
| Analysis of substance using immunoassay technique, multiple step method | 116 | $2,995 | $11 |
| New patient problem focused exam of visual system | 34 | $1,917 | $56 |
| Measurement of corneal curvature and depth of eye | 36 | $1,848 | $21 |
| Exam of the internal drainage system of eye | 61 | $1,308 | $21 |
| Photography of the retina | 17 | $494 | $29 |
| Ultrasound scan of cornea to determine thickness | 29 | $212 | $7 |
2022: 11 services
| Established patient complete exam of visual system | 93 | $11,407 | $108 |
| Established patient problem focused exam of visual system | 70 | $7,077 | $80 |
| New patient complete exam of visual system | 56 | $6,290 | $112 |
| Closure of tear duct opening using plug | 15 | $2,770 | $185 |
| Exam of visual field with extended testing | 32 | $1,753 | $55 |
| Imaging of optic nerve | 49 | $1,626 | $33 |
| Microfluid analysis of tears | 27 | $1,190 | $22 |
| Exam of the internal drainage system of eye | 50 | $1,165 | $23 |
| Imaging of retina | 24 | $786 | $33 |
| Analysis of substance using immunoassay technique, multiple step method | 23 | $520 | $11 |
| Ultrasound scan of cornea to determine thickness | 24 | $217 | $9 |
Drugs they prescribed that Part D paid
$1,875,343
Pharmacies billed $1,875,343 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,564) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
1,370 generic and 1,194 brand-name prescriptions · $1,875,343 in drug cost · 69 antibiotic prescriptions to 61 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Oxervate | 27 | $1,403,672 | $51,988 |
| Tyrvaya | 62 | $56,812 | $916 |
| Xiidra | 43 | $52,961 | $1,232 |
| Restasis | 41 | $48,699 | $1,188 |
| Miebo | 35 | $44,762 | $1,279 |
See all 30 drugs
| Oxervate | 27 | $1,403,672 | $51,988 |
| Tyrvaya | 62 | $56,812 | $916 |
| Xiidra | 43 | $52,961 | $1,232 |
| Restasis | 41 | $48,699 | $1,188 |
| Miebo | 35 | $44,762 | $1,279 |
| Cequa | 45 | $44,026 | $978 |
| Rocklatan | 76 | $38,651 | $509 |
| Lumigan | 74 | $36,459 | $493 |
| Cyclosporine | 23 | $14,181 | $617 |
| Prolensa | 36 | $12,463 | $346 |
| Bromfenac | 73 | $12,267 | $168 |
| Ilevro | 32 | $11,845 | $370 |
| Rhopressa | 22 | $9,869 | $449 |
| Brimonidine | 157 | $8,791 | $56 |
| Besivance | 38 | $8,329 | $219 |
| Difluprednate | 74 | $7,038 | $95 |
| Prednisolone Acetate | 237 | $6,078 | $26 |
| Simbrinza | 11 | $5,326 | $484 |
| Moxifloxacin | 198 | $5,006 | $25 |
| Tobramycin-Dexamethasone | 112 | $3,835 | $34 |
| Latanoprost | 436 | $3,521 | $8 |
| Dorzolamide-Timolol | 251 | $3,100 | $12 |
| Brimonidine Tartrate-Timolol | 26 | $2,503 | $96 |
| Timolol Maleate | 122 | $999 | $8 |
| Gatifloxacin | 23 | $959 | $42 |
| Doxycycline Hyclate | 57 | $861 | $15 |
| Acetazolamide | 15 | $525 | $35 |
| Dorzolamide | 27 | $309 | $11 |
| Neomycin-Polymyxin-Dexameth | 30 | $307 | $10 |
| Erythromycin | 19 | $146 | $8 |
Year by year
| 2024 | 2,564 | 715 | 0% (0) | 47% | $1,875,343 |
| 2023 | 2,467 | 572 | None | 46% | $419,308 |
| 2022 | 427 | 144 | 0% (0) | 46% | $62,312 |
| 2019 | 61 | 16 | 0% (0) | 31% | $6,124 |
| 2018 | 19 | None | 0% (0) | None | $1,188 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 33 drugs
| Restasis | 91 | $78,348 | $861 |
| Rocklatan | 80 | $35,735 | $447 |
| Prolensa | 89 | $32,275 | $363 |
| Cequa | 40 | $29,595 | $740 |
| Xiidra | 35 | $27,517 | $786 |
| Rhopressa | 49 | $22,233 | $454 |
| Besivance | 67 | $15,412 | $230 |
| Brimonidine | 172 | $14,725 | $86 |
| Tyrvaya | 18 | $11,987 | $666 |
| Difluprednate | 100 | $11,892 | $119 |
| Lumigan | 26 | $11,797 | $454 |
| Cyclosporine | 31 | $8,708 | $281 |
| Combigan | 25 | $8,477 | $339 |
| Ilevro | 21 | $8,235 | $392 |
| Vyzulta | 13 | $7,981 | $614 |
| Moxifloxacin | 128 | $5,196 | $41 |
| Prednisolone Acetate | 160 | $5,160 | $32 |
| Latanoprost | 384 | $5,135 | $13 |
| Dorzolamide-Timolol | 219 | $5,023 | $23 |
| Brimonidine Tartrate-Timolol | 32 | $3,785 | $118 |
| Tobramycin-Dexamethasone | 74 | $3,741 | $51 |
| Bromfenac | 33 | $3,466 | $105 |
| Travoprost | 27 | $2,424 | $90 |
| Simbrinza | 11 | $2,256 | $205 |
| Timolol Maleate | 175 | $1,778 | $10 |
| Dorzolamide-Timolol | 11 | $1,199 | $109 |
| Gatifloxacin | 33 | $1,129 | $34 |
| Doxycycline Hyclate | 51 | $1,112 | $22 |
| Dorzolamide | 40 | $964 | $24 |
| Acetazolamide | 33 | $631 | $19 |
| Neomycin-Polymyxin-Dexameth | 33 | $372 | $11 |
| Doxycycline Monohydrate | 20 | $268 | $13 |
| Erythromycin | 28 | $242 | $9 |
2022: 10 drugs
| Restasis | 29 | $19,529 | $673 |
| Rhopressa | 16 | $5,725 | $358 |
| Brimonidine | 29 | $2,659 | $92 |
| Tobramycin-Dexamethasone | 16 | $1,059 | $66 |
| Prednisolone Acetate | 28 | $950 | $34 |
| Latanoprost | 87 | $922 | $11 |
| Moxifloxacin | 18 | $876 | $49 |
| Doxycycline Hyclate | 16 | $821 | $51 |
| Dorzolamide-Timolol | 36 | $788 | $22 |
| Timolol Maleate | 37 | $356 | $10 |
Money from drug and device companies
$1,754 in 2025
| 2025 | 11 | 47 | None | $1,754 |
| 2024 | 9 | 37 | None | $1,299 |
| 2023 | 5 | 12 | None | $668 |
| 2022 | 2 | 2 | None | $35 |
| 2019 | 1 | 1 | None | $100 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alcon Vision | Clareon Panoptix Pro | $376 | 6 payments
|
| Amgen | Tepezza | $248 | 8 payments
|
| Tarsus Pharmaceuticals | Xdemvy | $244 | 8 payments
|
| Abbvie | Lumigan | $212 | 9 payments
|
| Dompe US | Oxervate | $167 | 4 payments
|
| Sun Pharmaceutical Industries | Cequa | $156 | 5 payments
|
See all 47 published payments
| Harrow Eye | Meals · 2025-12-19 | Vevye | $36 |
| Alcon Vision | Meals · 2025-12-04 | Clareon Panoptix Pro | $146 |
| Alcon Vision | Meals · 2025-11-11 | Argos | $15 |
| Apellis Pharmaceuticals | Meals · 2025-11-04 | Syfovre | $82 |
| Harrow Eye | Meals · 2025-10-31 | Vevye | $34 |
| Amgen | Meals · 2025-10-29 | Tepezza | $127 |
| Alcon Vision | Meals · 2025-10-28 | Clareon Panoptix Pro | $40 |
| Sun Pharmaceutical Industries | Meals · 2025-10-28 | Cequa | $19 |
| Sun Pharmaceutical Industries | Meals · 2025-10-28 | Cequa | $10 |
| Amgen | Meals · 2025-10-17 | Tepezza | $10 |
| Abbvie | Meals · 2025-10-10 | Lumigan | $33 |
| Tarsus Pharmaceuticals | Meals · 2025-09-16 | Xdemvy | $9 |
| Alcon Vision | Meals · 2025-09-12 | Clareon Panoptix Pro | $36 |
| Abbvie | Meals · 2025-09-05 | Lumigan | $34 |
| Tarsus Pharmaceuticals | Meals · 2025-08-29 | Xdemvy | $33 |
| Alcon Vision | Meals · 2025-08-15 | Clareon Panoptix Pro | $135 |
| Tarsus Pharmaceuticals | Meals · 2025-08-12 | Xdemvy | $9 |
| Amgen | Meals · 2025-08-06 | Tepezza | $25 |
| Abbvie | Meals · 2025-08-01 | Lumigan | $6 |
| Abbvie | Meals · 2025-08-01 | Lumigan | $21 |
| Tarsus Pharmaceuticals | Meals · 2025-07-29 | Xdemvy | $21 |
| Sun Pharmaceutical Industries | Meals · 2025-07-25 | Cequa | $11 |
| Abbvie | Meals · 2025-06-13 | Lumigan | $3 |
| Abbvie | Meals · 2025-06-13 | Lumigan | $24 |
| Tarsus Pharmaceuticals | Meals · 2025-06-10 | Xdemvy | $21 |
| Amgen | Education · 2025-05-30 | Tepezza | $8 |
| Amgen | Meals · 2025-05-28 | Tepezza | $25 |
| Dompe US | Meals · 2025-05-15 | Oxervate | $115 |
| Sun Pharmaceutical Industries | Meals · 2025-05-13 | Cequa | $22 |
| Tarsus Pharmaceuticals | Meals · 2025-05-12 | Xdemvy | $120 |
| Dompe US | Meals · 2025-05-02 | Oxervate | $22 |
| Tarsus Pharmaceuticals | Meals · 2025-04-29 | Xdemvy | $8 |
| Amgen | Meals · 2025-04-18 | Tepezza | $20 |
| Alcon Vision | Meals · 2025-04-10 | Clareon | $4 |
| Bausch & Lomb Americas | Meals · 2025-04-01 | Miebo | $24 |
| Abbvie | Meals · 2025-03-28 | Lumigan | $35 |
| Oyster Point Pharma | Meals · 2025-03-20 | Tyrvaya | $18 |
| Regeneron Healthcare Solutions | Meals · 2025-03-17 | Eylea Hd | $125 |
| Abbvie | Meals · 2025-03-07 | Lumigan | $32 |
| Amgen | Meals · 2025-03-05 | Tepezza | $30 |
| Harrow Eye | Meals · 2025-02-28 | Vevye | $32 |
| Amgen | Meals · 2025-02-19 | Tepezza | $4 |
| Dompe US | Meals · 2025-02-11 | Oxervate | $8 |
| Dompe US | Meals · 2025-02-11 | Oxervate | $22 |
| Abbvie | Meals · 2025-02-06 | Lumigan | $24 |
| Sun Pharmaceutical Industries | Meals · 2025-02-05 | Cequa | $95 |
| Tarsus Pharmaceuticals | Meals · 2025-01-31 | Xdemvy | $24 |
See earlier years (2024, 2023, 2022, 2019)
2024: $1,299
| Alcon Vision | Clareon | $366 | 10 payments
|
| Glaukos | Istent Trabecular Micro-Bypass System Model Is3 | $215 | 1 payment
|
| Abbvie | Lumigan | $187 | 7 payments
|
| Astellas Pharma US | Izervay | $125 | 1 payment
|
| Dompe US | Oxervate | $110 | 4 payments
|
| Oyster Point Pharma | Tyrvaya | $90 | 4 payments
|
| Sun Pharmaceutical Industries | Cequa | $86 | 4 payments
|
| Harrow Eye | Vevye | $60 | 3 payments
|
| Bausch & Lomb Americas | Miebo | $59 | 3 payments
|
2023: $668
| Sun Pharmaceutical Industries | Cequa | $184 | 3 payments
|
| Oyster Point Pharma | Tyrvaya | $175 | 4 payments
|
| Biotissue Holdings | Prokera | $166 | 2 payments
|
| Astellas Pharma US | Izervay | $110 | 1 payment
|
| Alcon Vision | Rocklatan | $33 | 2 payments
|
2022: $35
| Novartis Pharmaceuticals | Xiidra | $20 | 1 payment
|
| Dompe US | Oxervate | $16 | 1 payment
|
2019: $100
| Allergan | None | $100 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.8 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1285138362
- Licence
- CA A177459California A177459: Current · expires 2028-04-30
- Trained
- Drexel University College of Medicine, 2018 · 8 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X); Student in a training program (390200000X)
- Mailing address
- 1835 Arch St Apt 1410, Philadelphia, PA, 19103
- NPI first listed
- 2018-03-22
- NPI last updated
- 2022-06-06
- NPI record certified
- 2022-06-06
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: One Medical Center Boulevard, Upland, PA, 19013